New research suggests a potential solution for chronic back pain: manipulating hormone levels to halt abnormal nerve growth within damaged spinal tissue. A study published in Bone Research details how parathyroid hormone (PTH) can reverse this process, offering a new understanding of how bone cells influence pain signaling in deteriorating spines. This isn’t just about managing symptoms; it’s about addressing the underlying biological causes of chronic back pain.
The Core Finding: Reversing Nerve Overgrowth
Researchers at Johns Hopkins University, led by Dr. Janet L. Crane, found that PTH activates natural signals which push pain-sensing nerves away from areas where they shouldn’t be. This is significant because chronic back pain often arises when nerves grow into regions of the spine where they don’t belong, increasing discomfort.
How Parathyroid Hormone Works
PTH is a naturally occurring hormone regulating calcium levels and bone remodeling. Synthetic PTH is already used for osteoporosis, but earlier research suggested it might also reduce bone-related pain. This study clarifies why : PTH stimulates osteoblasts (bone-building cells) to produce Slit3, a protein that repels nerve fibers.
The team used three mouse models – natural aging, surgical instability, and genetic predisposition – to confirm this effect. Treated mice showed denser, more stable vertebral endplates (the layers between spinal discs and vertebrae) and reduced sensitivity to pain after just one to two months of PTH injections. They tolerated pressure better, reacted slower to heat, and were more active.
The Molecular Mechanism: Slit3 and FoxA2
The study went further, identifying the molecular pathway behind this effect. PTH triggers osteoblasts to produce Slit3, which acts as a repellent for growing nerve fibers. Researchers confirmed this by removing Slit3 from osteoblasts, which eliminated PTH’s pain-reducing effects. They also discovered that FoxA2, a regulatory protein, is key to triggering Slit3 production in response to PTH. This level of detail is crucial for developing targeted therapies.
Implications for Human Treatment
While these findings come from animal studies, they may explain why some osteoporosis patients on PTH experience reduced back pain. Further human trials are needed, but this research lays the foundation for clinical trials exploring PTH as a disease-modifying treatment, not just a pain reliever.
“Our study suggests that PTH treatment of LBP during spinal degeneration may reduce aberrant innervation, laying the foundation for future clinical trials exploring the efficacy of PTH as a disease-modifying and pain-relief treatment for spinal degeneration.” – Dr. Janet L. Crane
This discovery represents a shift in how chronic back pain might be approached. Instead of simply masking the pain, this research suggests a way to correct the underlying biological dysfunction. The path to clinical application is still ahead, but the potential impact on millions suffering from chronic back pain is substantial.
